Project
Start
January 2019

The Global Epidemiology of RSV in Primary and Secondary Care (GERi) project

The Global Epidemiology of RSV in Primary and Secondary Care (GERi) project will assess differences in the epidemiology of respiratory syncytial virus (RSV) infections among patients in primary and secondary care around the world. The study will use existing surveillance data and provide important information for the future introduction of vaccination or monoclonal antibodies in these two settings.
Funding
Sanofi Pasteur
In this project we work together with
Multiple partners